College of American Pathologists Foundation

Nonprofit profile at a glance

EIN
366134600
IRS 990 coverage
2015–2024
Forms available
Form 990 2024
Location
Northfield, IL, USA
Phone
8478327000
Rating
72
Verdict
SUPPORTED
Rating confidence
Standard
Sector
Single Organization Support

Reported finances

Revenue
$1,138,242
Expenses
$1,064,468
Assets
$3,260,071
Liabilities
$326,365

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

25 people listed

Executive titles in this filing

  • BHARATI S JHAVERI MD FCAP (VICE-PRESIDENT)
  • EVA M WOJCIK MD FCAP (PRESIDENT)
  • MAYA OGDEN (EXECUTIVE DIRECTOR CAP FOUNDATION)

Highest reported compensation

  • STEPHEN R MYERS CAP CEO (DIRECTOR (THRU 03/2024)): $611,195 total reported compensation
  • MICHAEL FRASER CAP CEO (DIRECTOR (Start 03/2024)): $565,418 total reported compensation
  • MAYA OGDEN (EXECUTIVE DIRECTOR CAP FOUNDATION): $242,818 total reported compensation

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

See schedule o

What it reported doing in 2024

The foundation champions patient-centered and humanitarian roles for pathologists striving to connect people, especially those in need, to the specialized, life-saving skills of pathologists. See, test & treat is the foundation's flagship endeavor. It is a free, pathologist-led cervical and breast cancer-screening program offered to vulnerable women throughout the u.s. The foundation regards see, test & treat as a model program to spur engagement, reduce health disparities, and improve health outcomes in medically underserved communities. The foundation also confers educational training and leadership awards to pathology residents to increase the specialty's impact in healthcare. The cap foundation's reach extends far beyound u.s. Boarders. Through our gloabal pathology award and educational programs. We've received applications and supported awardees from countries around the world. This growing international network reflects our commitment to advancing pathology, expanding access to care, and empowering the next generation of pathologists. In 2024 17 countries were reached 37 grants or awards were distributed. See, test & treat is a life saving program that provides free cancer screening and helath education to medically underserved communities, delivering same-day results and follow-up care. Led by volunteer pathologists and supported by local health care teams, the program removes barriers to care and empowers patients with critical knowledge about their health. In 2024, 12 programs were hosted across the us, 600 uninsured and underinsured women were screened, 112 were connected to additional follow up care. The cap foundation's grants and awards support the next generation of pathologists through funding for leadership development, global health experiences and advanced access to education and strengthen the future of the pathology profession. In 2024, 30 grants and awards were given domestically, 30 students, residents and fellows were awarded.

Operating model

Revenue model
Mixed. Its operating money came from several sources; no one source provided a clear majority.
Distribution model
Hybrid. The nonprofit split its reported program spending across 74% for direct work, and 26% for grants.
  • Includes noncash contributions: Reported contributions include donated property or goods.

The verdict

SUPPORTED - A large share of available resources goes toward mission work and the filed numbers largely add up. The filing reports few safeguards for money sent abroad and fundraising costs are high for each dollar raised.

Rating breakdown

  • Financial Efficiency: 67
  • Transparency & Controls: 65
  • Accountability: 92
  • Sustainability: 56
  • Growth: 100

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 73.3%; rating input score 73
  • Program expense ratio: 73.5%; rating input score 73
  • Fundraising efficiency: $5.75 raised per $1 spent on fundraising; rating input score 21; 21st percentile among comparable filings

Transparency & Controls

  • Consistency checks: 93.3%; rating input score 93; 22nd percentile among comparable filings
  • Pay-setting controls: 1 of 6 controls in place; rating input score 17
    • Compensation committee: Missing
    • Independent consultant: Missing
    • Other Form 990s reviewed: Missing
    • Written employment contract: Missing
    • Compensation survey or study: Missing
    • Board or committee approval: Pass
  • Foreign activity oversight: 1 of 8 controls in place; rating input score 12
    • Claims monitoring procedures: Pass
    • Requires narrative reports: Fail
    • Conducts field audits: Fail
    • May suspend future funding: Fail
    • Requires financial reports: Fail
    • Conducts site visits: Fail
    • Requires grant agreements: Fail
    • May require repayment: Fail
  • Grant itemization coverage: 99.4%; rating input score 99; 49th percentile among comparable filings
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 94.4%; rating input score 94; 25th percentile among comparable filings
  • Governance controls: 7 of 8 controls in place; rating input score 88
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Pass
    • Document-retention policy: Pass
    • CEO compensation review process: Fail
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Pass
    • Independent financial-statement audit: Pass

Sustainability

  • Operating margin: 6.5%; rating input score 54; 54th percentile among comparable filings
  • Total-asset coverage ratio: 3.06; rating input score 76; 76th percentile among comparable filings
  • Liabilities to assets ratio: 0.1; rating input score 42; 42nd percentile among comparable filings
  • Officer compensation ratio: 12.4%; rating input score 29; 29th percentile among comparable filings

Growth

  • Program expense growth: 1.9% per year; rating input score 100; 26th percentile among comparable filings
  • Revenue growth: 1.4% per year; rating input score 100; 21st percentile among comparable filings
  • Asset growth: 1.8% per year; rating input score 100; 24th percentile among comparable filings

Details

  • Where the money goes: 73.3% of revenue deployed · 73.5% of spending went to programs
  • Governance: 17 of 18 board members independent · 7 of 8 filing controls reported
  • Programs: 1 filed program accomplishment · $782K in reported program spending
  • Leadership: top reported pay $611K · 25 people listed · 1 of 6 pay-setting controls reported
  • Consistency: 47 of 48 current checks pass · 1 finding to review
  • Schedules: 9 filed schedules · includes major donors, foreign activity, grants, and executive pay
  • Filing history: 9 filing years from 2015 to 2024
  • Contacts: How to reach this organization
  • Money network: 10 filed money-flow records
  • Related organizations: 11 filed related-organization links
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Transparency & Controls: Foreign activity oversight: 7 of 8 not reported.
  • High — Financial Efficiency: Fundraising efficiency scored 21/100.
  • Review — Sustainability: Operating margin scored 54/100.
  • Review — Accountability: Governance controls: CEO compensation review process not reported.
  • High — Sustainability: Officer compensation ratio scored 29/100.
  • Moderate — Sustainability: Liabilities to assets ratio scored 42/100.
  • Review — Transparency & Controls: Domestic grant itemization did not reconcile in the filed values.